ÂÜÀòÂÒÂ×

Peter Stueckemann is an experienced healthcare professional with extensive expertise in strategic accounts, business analytics, and commercial strategy. Currently serving as the Strategic Accounts Business Analytics Lead at Aurinia Pharmaceuticals Inc., Peter focuses on developing innovative commercial strategies to enhance treatment options for lupus nephritis patients. Previously, as Regional Sales Manager, Peter's region consistently ranked among the top nationally for new patient volumes despite low business indices. At UCB, Peter led patient marketing and access initiatives, while at AbbVie, Peter directed commercial strategy for U.S. Immunology Marketing, driving significant technological innovations. Peter's career began at TAP Pharmaceuticals, where Peter held various roles, including Business Development Executive and Group Marketing Manager, leading successful product launches and marketing campaigns. Peter holds an MBA in Negotiations & Business Law from Lake Forest Graduate School of Management and a Bachelor of Science in Chemical Engineering from Northwestern University.